Andrew Lichtman, MD, PhD, Professor of Pathology, Brigham & Women's Hospital and Harvard Medical School, Boston, Massachusetts
Dr. Lichtman received an A.B degree of Bowdoin College in 1974, and MD and PhD (Biophysics) degrees from the University of Rochester School of Medicine in 1981. He trained in anatomic pathology and completed a post-doctoral research fellowship at the Brigham and Women’s Hospital between 1982-1985. He is a diplomat of the American Board of Pathology, and currently holds the position of Professor of Pathology at Brigham and Women’s Hospital and Harvard Medical School. He has directed a continuously N.I.H. -funded research laboratory for over 25 years. His current research focuses on T cell-mediated pathological responses in cardiovascular disease and has published extensively in this field. In addition to his research-related activities, Dr. Lichtman is a staff pathologist at the Brigham and Women’s Hospital, directs Immunology and Pathology courses at Harvard Medical School (HMS), and is a coauthor of two widely used text books of immunology. He has received numerous teaching awards at HMS, and is the recipient of the 2014 Robbins Distinguished Educator Award of the American Society of Investigative Pathology. He has taught in postgraduate Immunology courses worldwide. He is a past Education Chair and current Publications Committee Chair of the Federation of Clinical Immunology Societies (FOCIS).
Shiv Pillai, MD, PhD, Professor of Medicine and Health Sciences and Technology Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
Dr. Pillai completed his medical studies at the Christian Medical College, Vellore, in south India, and went on to obtain a PhD in Biochemistry from Calcutta University. He was an investigator at the Kothari Center for Gastroenterology in Calcutta until 1983, and was a postdoctoral fellow at the Whitehead Institute in Cambridge from 1984-1988. Since 1988 he has been a faculty member at the Cancer Center and the Department of Medicine at Massachusetts General Hospital and Harvard Medical School. He discovered surrogate light chains and the pre-B receptor as a post-doctoral fellow, and his laboratory at MGH has been largely focused on studies on B lymphocyte development, signaling, tolerance, and more recently on the genetic basis of human autoimmune disorders. Dr. Pillai is on the Editorial Boards of the Journal of Clinical Investigation and the Journal of Immunology ,is the director of immunology courses taught at Harvard College and Harvard Medical School, and teaches in a number of other courses at both institutions. He has received numerous teaching awards, including the Irving London Award, is the author of Lymphocyte Development, and is co-author with Abul Abbas and Andrew Lichtman of Cellular and Molecular Immunology.
8:00-8:15 am Introduction & Overview - Andrew Lichtman, MD, PhD
8:15-9:15 am Innate Immunity - Andrew Lichtman, MD, PhD
9:15-10:15 am Antigen Presentation & T Cell Activation - Shiv Pillai, MD, PhD
10:15-11:15 am CD4 T Cells and Cytokines - Andrew Lichtman, MD, PhD
11:15 am - 12:15 pm CD8 T Cells, NK and NK-T Cells - Andrew Lichtman, MD, PhD
12:15-1:00 pm Lunch Break
1:00-2:00 pm B Cells and Antibodies - Shiv Pillai, MD, PhD
2:00-3:00 pm T Cell Regulation, Tolerance & Autoimmunity - Shiv Pillai, MD, PhD
Please take a moment to complete an evaluation of today's course here.